A detailed history of Jane Street Group, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 34,397 shares of KOD stock, worth $182,304. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,397
Previous 64,397 46.59%
Holding current value
$182,304
Previous $151,000 41.06%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.2 - $3.25 $66,000 - $97,500
-30,000 Reduced 46.59%
34,397 $89,000
Q2 2024

Aug 14, 2024

SELL
$2.29 - $4.48 $23,007 - $45,010
-10,047 Reduced 13.5%
64,397 $151,000
Q1 2024

May 15, 2024

SELL
$3.01 - $7.45 $141,394 - $349,963
-46,975 Reduced 38.69%
74,444 $391,000
Q4 2023

Feb 14, 2024

BUY
$1.4 - $3.24 $102,561 - $237,355
73,258 Added 152.11%
121,419 $369,000
Q3 2023

Nov 14, 2023

SELL
$1.8 - $7.49 $119,293 - $496,392
-66,274 Reduced 57.91%
48,161 $86,000
Q2 2023

Aug 14, 2023

BUY
$4.3 - $9.48 $395,148 - $871,164
91,895 Added 407.7%
114,435 $789,000
Q1 2023

May 15, 2023

BUY
$4.81 - $8.88 $15,565 - $28,735
3,236 Added 16.76%
22,540 $139,000
Q4 2022

Feb 14, 2023

SELL
$6.52 - $8.05 $162,602 - $200,758
-24,939 Reduced 56.37%
19,304 $138,000
Q3 2022

Nov 14, 2022

SELL
$7.57 - $12.5 $238,144 - $393,237
-31,459 Reduced 41.56%
44,243 $342,000
Q2 2022

Aug 16, 2022

BUY
$5.04 - $9.48 $151,880 - $285,679
30,135 Added 66.13%
75,702 $578,000
Q1 2022

May 17, 2022

BUY
$7.09 - $89.45 $228,595 - $2.88 Million
32,242 Added 241.97%
45,567 $352,000
Q4 2021

Feb 15, 2022

BUY
$80.85 - $128.49 $105,590 - $167,807
1,306 Added 10.87%
13,325 $1.13 Million
Q3 2021

Nov 16, 2021

BUY
$81.97 - $106.94 $194,268 - $253,447
2,370 Added 24.56%
12,019 $1.15 Million
Q2 2021

Aug 16, 2021

BUY
$77.2 - $126.54 $283,941 - $465,414
3,678 Added 61.6%
9,649 $897,000
Q1 2021

May 18, 2021

SELL
$110.45 - $164.47 $5.92 Million - $8.82 Million
-53,618 Reduced 89.98%
5,971 $677,000
Q4 2020

Feb 17, 2021

BUY
$60.78 - $154.03 $2.61 Million - $6.63 Million
43,023 Added 259.71%
59,589 $8.75 Million
Q3 2020

Nov 17, 2020

BUY
$45.05 - $59.27 $746,298 - $981,866
16,566 New
16,566 $981,000
Q1 2020

May 15, 2020

SELL
$38.18 - $73.95 $248,246 - $480,822
-6,502 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$13.9 - $76.65 $90,377 - $498,378
6,502 New
6,502 $468,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $276M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.